ICYMI #NCPA2025: Fair Pricing for Type 2 Diabetes Care
Coming to you from the #NCPA2025 expo floor, host John Beckner and co-host Ed Cohen talk with Brian Connelly, president and CEO of TheracosBio, about Brenzavvy (bexagliflozin), an FDA-approved oral SGLT2 inhibitor for adults with Type 2 diabetes. They discuss how the company's model bypasses PBMs to offer pharmacists and patients a fair, transparent price.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.